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Abstract
Background: Blood coagulation is a complex network of biochemical reactions, which is peculiar in that it is time-
and space-dependent, and has to function in the presence of rapid flow. Recent experimental reports suggest that
flow plays a significant role in its regulation. The objective of this study was to use systems biology techniques to
investigate this regulation and to identify mechanisms creating a flow-dependent switch in the coagulation onset.
Results: Using a detailed mechanism-driven model of tissue factor (TF)-initiated thrombus formation in a two-
dimensional channel we demonstrate that blood flow can regulate clotting onset in the model in a threshold-like
manner, in agreement with existing experimental evidence. Sensitivity analysis reveals that this is achieved due to a
combination of the positive feedback of TF-bound factor VII activation by activated factor X (Xa) and effective
removal of factor Xa by flow from the activating patch depriving the feedback of “ignition”. The level of this trigger
(i.e. coagulation sensitivity to flow) is controlled by the activity of tissue factor pathway inhibitor.
Conclusions: This mechanism explains the difference between red and white thrombi observed in vivo at different
shear rates. It can be speculated that this is a special switch protecting vascular system from uncontrolled
formation and spreading of active coagulation factors in vessels with rapidly flowing blood.
Background
Blood coagulation is a complex reaction network that
functions to form a fibrin clot that covers damaged ves-
sel wall and prevents blood loss [1]. The clotting process
is initiated by tissue factor (TF), a transmembrane pro-
tein exposed in the damaged parts of the wall. This pro-
tein forms a complex called extrinsic tenase with plasma
protein activated factor VII (VIIa). Extrinsic tenase acti-
vates factor X, which activates thrombin, the main pro-
tein of blood coagulation. Activated factor X (factor Xa)
activates factor VII in complex VII-TF (inactive extrinsic
tenase), thus forming a positive feedback. Extrinsic
tenase is inhibited by tissue factor pathway inhibitor
(TFPI) in a complex factor Xa-dependent manner [2].
Thrombin forms fibrin, which polymerizes to create a
clot.
Although reactions of the coagulation cascade are well
known, and no new essential components of this system
have been discovered over the last fifteen years [1], the
present understanding of the functioning of this system
is limited. The incredible biochemical complexity of coa-
gulation additionally complicated by protein diffusion
and blood flow makes it extremely difficult to establish
a correlation between the roles of individual reactions
and the functioning of the clotting system in vivo as a
whole. For diffusion, a number of recent studies brought
attention to the essential role of spatial non-uniformity
and rate-limiting diffusion of specific coagulation factors
thus proposing new concepts of clotting regulation,
alternative to the classic “cascade” paradigm [1,3-6].
This is not the case for blood flow.
A major role of flow in hemostasis and thrombosis
was recognized as early as 19th century, flow being one
of the components of the famous Virchow’st r i a d[ 7 ] .
Two primary hemostatic mechanisms, platelet plug for-
mation and blood coagulation, are known to differently
depend on the flow conditions: platelet adhesion and
aggregation require high blood flow velocities, while
fibrin deposition occurs better in slowly flowing blood
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any medium, provided the original work is properly cited.[8,9]. Moreover, a recent report suggests that fibrin clot
formation is inhibited by flow in a threshold-like man-
ner [10]. This can be illustrated in vivo by formation of
fibrin-rich red thrombi containing erythrocytes in veins
(where shear rate is low) and of platelet-rich white
thrombi in arteries [11]. However, the phenomenon of
blood clotting inhibition by flow has not been studied in
detail and was assumed to be a self-evident consequence
of the removal of active coagulation factors from the
site of vascular damage by flow.
In order to gain insight into this phenomenon, a mod-
ular decomposition strategy was used. We created a
detailed quantitative mechanism-driven mathematical
model of thrombus formation in flowing plasma. In
agreement with experimental reports, clot formation in
the model depended on blood flow shear rate in a
threshold-like manner. Sensitivity analysis of this model
was performed to identify reactions forming a module
(or subsystem) within this biochemical network that was
responsible for this effect. We demonstrated that a spe-
cially designed positive feedback of factor VII activation
combined with chemical inhibition of extrinsic tenase
and flow-induced removal of factor Xa becomes a
“switcher” that can “decide": whether to start clotting or
to abstain from it. It can be speculated that this switch-
ing can serve to prevent uncontrolled spreading of coa-
gulation factor by flow throughout the vasculature.
Results
The effect of flow on fibrin thrombus formation
Functioning of blood coagulation network was simulated
in a two-dimensional region with constant pressure flow
as described under Methods. Fig. 1 (see also Additional
files 1 and 2) illustrates the design of computational
experiments and the general effect of flow on coagula-
tion. The clot initially appeared downstream from the
activator and slowly propagated upstream; the clot size
downstream from the activator was much greater than
the activator size. This clotting downstream from the
activator, which may seem not physiological, was most
likely caused by lack of thrombomodulin and heparane
sulfate on the chamber walls in our simulations. Throm-
bomodulin present on the endothelium of vessels, is
able to inhibit spatial clot propagation [4] and is prob-
ably responsible for the lack of uncontrolled fibrin for-
mation downstream from the damage site in vivo.
However, this study was focused on the initial stages of
clot formation, which are not influenced by thrombo-
modulin [4]; therefore, we chose not include this addi-
tional system into the model. Further, it is interesting to
note that the clot is heterogeneous: the high density
region (Fn concentration higher than 3,800 nM, i.e.
more than 1/2 of fibrinogen concentration) is localized
near the activator (dark grey in Fig. 1), while the large
thrombus downstream primarily consisted of low den-
sity clot (dark blue in Fig. 1).
This following study was concentrated on the most
obvious and immediate effect of the flow, the increase
of time between TF exposure and the clot appearance.
In order to characterize this quantitatively, we intro-
duced the parameter of lagtime, i.e. time required to
cover half of the activator with high density fibrin clot
(3,800 nM).
A series of computational experiments on fibrin throm-
bus formation at different flow rates was performed. Fig.
2a (black line) shows the above-defined lagtime as a func-
tion of wall shear rate. It can be approximated with a func-
tion of exponential growth y = a+be
c·x,a= 1.54 ± 0.73,
b = 2.86 ± 0.32, c = 0.129 ± 0.004, where y is lagtime and
x is wall shear rate. From a practical point of view, this
means that, at small shear rates (0-13 s
-1), the lagtime
increased slowly with the increase of shear rate from 2.5
min without flow up to 10-20 min. However, this increase
became very rapid at higher shear rates, and by 28 s
-1 the
lag time reached 100-120 min. The results in Fig. 2a can
be summarized as follows: 1) clotting is inhibited by flow;
2) this inhibition is strongly non-linear, i.e. the system can
resist inhibition caused by flow within a certain range of
flow rate, but it is efficiently “turned off” at higher shear
rates.
Dependence of the phenomena on model assumptions
While the vast majority of model parameters are based
on experimental data and have been thoroughly vali-
dated by comparison with experiments without flow [4],
two assumptions were made in this study: specific values
for fibrin gelation concentration and the fibrin level to
calculate lagtime. In order to estimate the effect of these
assumptions, we performed calculations at different
values. For this, we introduced two numerical para-
meters characterizing control of clotting by flow: Cij
S

(overall inhibition of clotting by flow in the interval of
shear rates i-j) and R’ (non-linearity of this inhibition) as
defined under Methods.
T h ei n c r e a s eo ft h eg e l a t i o np o i n tc o n c e n t r a t i o n
increased the influence of flow on the system and vice
versa quantitatively, but not qualitatively. The principal
effect (that coagulation system can resist flow within
some range of flow velocities and is suppressed by more
rapid flow) remained (Fig. 2a, Table 1). Furthermore,
the exact value of fibrin concentration at which clot
became solid did not influence the observed flow effect
at all (Fig. 2b, Table 1). The most likely explanation is
that, when a portion of the activator became protected
from the flow by the clot, coagulation reactions within
the clot could proceed rapidly, and complete fibrinogen
conversion could occur with minimal delays.
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activator size
The simulations described above were carried out with
the same activator size of 1000 μm. The damaged area
in vivo can vary, and it was necessary to find out how
the observed phenomena depended on activator size. In
order to do this, we determined the dependence of the
lag-time on the activator size (Fig. 3a) with wall shear
rate being kept constant (17 s
-1). Increase of the activa-
tor size led to the lagtime decrease and vice versa. The
dependence was hyperbolical as evidenced by linearity
in a semi-reciprocal scale (Fig. 3a inset). There was
almost no clotting (at this shear rate) for activators
smaller than 500 μm. Additional simulations at different
wall shear rates confirmed that all observed phenomena
existed at different activation sizes although the specific
values of clotting time could change (data not shown).
Lagtime dependence on wall shear rate calculated for
the 500 μm-long activating patch is presented in Fig. 3b.
For this case C
S
01 5  =3 . 3 5a n dR’ =2 . 1i nc o m p a r i s o n
with 1000 μm -long activating patch. Influence of flow
increased 3-fold and system became 2-fold more sensi-
tive to flow rate variation, although all phenomena
remained.
Chemical reaction as a sensor of flow: a new role for
factor VII activation by factor Xa
In previous sections, we found out that the dependence
of clotting initiation on wall shear rate is strongly non-
linear. We were also able to show that this phenomenon
did not essentially depend on our assumptions and acti-
vation conditions. The next step was to figure out the
chemical mechanism responsible for this behavior of
coagulation system under flow conditions. As a first
approach to identify critical elements of the system
affected by flow, we carried out virtual experiments,
where individual coagulation factors were not carried by
flow. In order to “switch off” their convection we
removed the respective convection terms from the equa-
tions for these factors (see model description). This
approach allowed individual coagulation factors to
“ignore” the flow thus illustrating the relative contribu-
tion of their convection. Red line in Fig. 4a represents
the same dependence of lag-time on the wall shear rate
in a model experiments without convection of all zymo-
g e n s( i . e .f a c t o r sI I ,V ,V I I ,V I I I ,I X ,X ,X I ,F i b r i n o g e n ) .
We can see that convection of these factors does not
affect the initial phase of clot growth. Coefficients Cij
S

and R’ for these cases are presented in Table 1. They
show quantitatively that there was no significant differ-
ence with normal coagulation.
This was not the case with enzymes (blue line in Fig. 4a).
When convection of all enzymes (i.e. factors IIa, Va, VIIa,
VIIIa, IXa, Xa, XIa, activated protein C) was “switched
off”, clot formation within the total range of flow rates was
exactly the same as for the zero shear rate. Neither lagtime
(Fig. 4a) nor clot shape (data not shown) depended on wall
shear rate. C
S
02 8  = 0 and R’ could not be calculated at all,
as the lagtime dependence on wall shear rate could be
Figure 1 Fibrin clot in the presence of flow. Computer simulations were performed as described under the Methods section. Size of
simulation area 1000 μm × 6000 μm; activator size 1000 μm. The time is 0 min (a), 15 min (b) and 25 min (c) since the beginning of
coagulation, wall shear rate is 17 s
-1. Arrow shows the direction of flow. Blue-red gradient shows the value of horizontal component of flow
velocity: the more reddish is the colour, the greater is this component. Top and bottom boundaries are impermeable to flow. Green line at the
bottom is activator (site, covered with TF). Dark gray shows solid clot (fibrin exceeds 3,800 nM). Dark blue shows the rest of the clot, consisting
of low concentration fibrin. The detailed kinetics of thrombus formation can be found in Additional files 1 and 2.
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completely insensitive to flow. Thus, it is the removal of
active factors by flow that changes the coagulation system
behavior under flow conditions.
Further analysis carried out by analogy revealed speci-
fic enzymes responsible for the effect. “Switching off”
convection of factors IIa and Xa only had the same
effect as that of all enzymes taken together (magenta
line in Fig. 4a, table 1). R’ could not be calculated, and
C
S
02 8  was very low (0.01). Additional analysis showed
that individual contributions of factors IIa and Xa to the
phenomenon were comparable (data not shown). When
convection of all enzymes except for factors IIa and Xa
(i.e. Va, VIIa, VIIIa, IXa, XIa, activated protein C) was
turned off (dark cyan line in Fig. 4a, Table 1), the influ-
ence of flow on coagulation system was reduced
approximately 2.6-fold (C
S
01 5  = 0.39), while sensitivity
to flow rate variation was reduced by a factor of 1.6 (R’
= 0.63). This remaining difference was due to factor Va
convection: turning on factor Va convection in this
Figure 2 Dependence of lagtime on flow shear rate at different fibrin gelation parameters. (a) Lagtime dependence is quantitatively, but
not qualitatively influenced by the fibrin gelation point. In most simulations, we used fibrin concentration of 450 nM as a point of gelation
(black). Here we show that increase of this value up to 760 nM (red) reduces range of flow rates, where coagulation resists flow, but the overall
effect of flow does not change. Decreasing the value of fibrin gelation point down to 380 nM (blue) prolongs this range. (b) Lagtime is not
influenced by the of choice concentration, where we assume fibrin to form a solid clot. Throughout the study, we used value of 3,800 nM. This
figure shows the changing this value has no effect.
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(data not shown). Summarizing, these simulations pro-
vide evidence that it is convection of factors IIa and Xa
that determines the effect of system sensitivity to flow
rate variation.
After identification of the specific factors, removal of
which by flow is most important for the regulation of
coagulation system behavior under flow conditions, we
analyzed the reactions, wherein these factors participate
by their removal from the system. Thrombin-mediated
cleavage of fibrinogen and prothrombin activation by fac-
tor Xa are essential and critical components of the coa-
gulation system, and their removal from the reaction
scheme could not be attempted. Other important reac-
tions involving these enzymes are positive feedback loops
of factors V, VII, VIII, XI activation by thrombin, and of
the factor VII-TF complex activation by factor Xa [12].
We found out that “switching off” all positive feedbacks
catalyzed by thrombin caused moderate increase of Cij
S

and almost did not change R’ (blue line in Fig. 4b). Thus,
although system was slightly better suppressed by flow,
its sensitivity to flow rate variation remained on the same
level (R’ = 1.12). This was not the case for factor Xa-cata-
lysed reactions: “turning off” the factor VII-TF complex
activation (red line in Fig. 4b) made the system 3-fold
less sensitive to flow rate variation (R’ = 0.33), and it was
suppressed by flow 7.7-fold better.
We propose the following explanation of observed
phenomena: the onset of blood coagulation under flow
conditions is governed by the positive feedback of
extrinsic tenase activation by factor Xa. When flow does
not influence this feedback (as it was in the case of no
convection of factors Xa and IIa), the duration of clot-
ting initiation phase becomes independent of flow rate.
When the feedback does not function (factor Xa does
not activate complex VII-TF to its active form, extrinsic
tenase) flow suppresses coagulation, although this influ-
ence varies little as flow rate is increased. But in normal
case, flow gradually switches off feedback extrinsic
tenase activation. This not only causes lagtime increase,
but also makes this increase non-linear.
Flow-dependent regulation of extrinsic tenase production
Extremely long lagtimes observed in the simulations in
the presence of flow can appear unusual, because TFPI
usually limits the lifetime of extrinsic tenase to several
minutes [13]. To better investigate the events occurring
during the initiation stage of clotting in flow, the inte-
gral extrinsic tenase kinetics was simulated and com-
p a r e df o rt h r e ed i f f e r e n tc a s e s :a )s t a g n a n tp l a s m a( w a l l
shear rate 0 s
-1); b) moderate flow (wall shear rate 7 s
-1);
c) rapid flow (wall shear rate 23 s
-1). The results are
shown in the Fig. 5a. Lagtimes are marked with arrows.
In stagnant plasma, almost all extrinsic tenase is inhib-
ited by the 24
th minute of experiment (integral value of
extrinsic tenase is lower than 0.1 × 10
-6 nmole/mm).
The moderate flow decreased the rate of extrinsic tenase
accumulation and the maximal concentration achieved,
but it also prolonged its existence up to 31 minutes.
Table 1 Effect of system perturbation on sensitivity to flow
Condition Cij
S
 R’
i-j, s
-1
Control, Fn gel concentration 380 nM 0.76 0-28 0.81
Control, Fn gel concentration 760 nM 2.72 0-20 2.05
Control, Fn concentration of solid clot 450 nM 0.97 0-28 1
Control, Fn concentration of solid clot 7600 nM 1.02 0-28 1.01
Control 1 0-28 1
Control (activator size 500 μm) 3.35
1 0-15 2.1
1
No convection of zymogens 1.03 0-28 1
No convection of enzymes 0 0-28 -
No convection of enzymes except for IIa & Xa 0.39
2 0-15 0.63
2
No convection of IIa & Xa 0.01 0-28 -
No Xa-induced VII-TF activation 7.73 0-12 0.33
No IIa-induced activation of V, VII, VIII, XI 1.72 0-12 1.12
Addition of TFPI at 5 nM 5.55 0-12 4.5
Addition of AT-III at 6800 nM 1.38 0-24 1.22
Addition of VIIa at 10 nM 0.07 0-24 0.25
Table 1 indicates how perturbations of the coagulation system alter its behavior (length of coagulation onset) under flow conditions. Two coefficients represent
two different types of flow induced influence on this system (see Methods). Cij
S
 shows whether system is suppressed by flow (within range of flow rates from
is
-1 up to j s
-1) better or worth than in normal case (Cij
S
 >1o rCij
S
 < 1). Each set of simulation results was approximated, where it was possible, with
exponential function of the following type: y = y0 + A·e
R·x. Parameter R’ shows whether system became more sensitive to flow rate variation than in normal case
(R’ >1o rR’ <1 ) .
1 Coefficient calculated relatively to normal case (1000 um activator length)
2 Coefficient calculated relatively to normal case (500 um activator length)
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under the rapid flow conditions. During the first 10
minutes, TF could bind factor VIIa circulating in blood
at a small concentration. However, formation of the
peak was inhibited by flow because of the removal of
factor Xa and the resulting decrease of TF-VII activa-
tion. Subsequently, slow inhibition of extrinsic tenase
began, but then a new peak appeared, and it causes the
onset of coagulation. This peak appears when about a
half of the activator is covered by the clot (time, when
initiation phase considered to be finished) and thus pro-
tected from the flow. If thrombin-induced fibrinogen
conversion was removed from the model, and thus no
clot could be formed, the second peak disappeared.
Figure 3 Dependence of lagtime on activator size. (a) All simulations were carried out as in Fig. 1, except for the difference in activator size.
Wall shear rate is 17s
-1. The inset shows the dependence in a semi-reciprocal scale. (b) 1) normal case, activator size 500 μm; 2) activator size
500 μm, no convection of all enzymes except for factors IIa and Xa; 3) normal case, activator size 1000 μm.
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ferent shear rates. It illustrates that flow actually pro-
longs the lifetime of extrinsic tenase. Summarizing, the
calculations in Fig. 5 show that flow plays a dual role in
the regulation of extrinsic tenase. On the one hand,
extrinsic tenase formation is slowed down, and clot is
slower to form. On the other hand, this protects TF
from inhibition (it can be inhibited only in complex
with VIIa) and thus flow can prolong the life time of
extrinsic tenase and allow clot initiation later.
Possible tests of the model predictions
Although the “flow-dependent trigger” obtained in our
model was in agreement with experimental evidence
[10,14,15] and did not require any hypotheses about
unknown reactions, its mechanism remains to be experi-
mentally confirmed. The most direct way to do this
would be to study coagulation in a flow chamber using
mutant molecules of factors X and VII that would be
unable to participate in some of the feedback reactions.
However, there are simpler experiments that can be
undertaken to test tis mechanism, and we attempted to
predict them with the help of the model.
Addition of 10 nM factor VIIa (equal to the plasma
concentration of factor VII) in the model dramatically
shortened the lagtime (its suppression by flow was
reduced 14-fold, C
S
02 4  = 0.07), and decreased sensitiv-
ity to flow rate variation 4-fold (R’ =0 . 2 5 )( F i g .6 ) .T h a t
the sensitivity to flow rate variation in plasma, where
Figure 4 Dependence of lag time on shear rate is determined by the factor VII activation by factor Xa. (a) Lag time as a function of wall
shear rate in the range of shear rates of 0-27 s
-1. The channel was 1 mm wide, and the activator was 1 mm long. The lines show: 1) normal
plasma (black); 2) all zymogens (factors II, V, VII, VIII, IX, X, XI, PC, Fibrinogen) do not move with the flow (red); 3) all enzymes (factors IIa, Va, VIIa,
VIIIa, IXa, Xa, XIa, PCa) do not move with the flow (blue); 4) no convection of all enzymes except for factors IIa and Xa (magenta); 5) no
convection of factors IIa and Xa only (dark cyan). As can be seen from these curves, the dependence is predominantly determined by the
convection of factors IIa and Xa. (b) Lag time as a function of wall shear rate without factor IIa-dependent reactions. The lines show: 1) normal
plasma (black); 2) no factor IIa-dependent reactions except for fibrinogen cleavage (blue); 3) no factor VII-TF complex activation by factor Xa
(red). It can be seen that the factor Xa-dependent activation of the factor VII-TF complex plays a critical role in the formation of the non-linear
response of blood coagulation to flow.
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very low, would be the most important and clear confir-
mation of the principal conclusion of this study: that it
is the positive feedback of factor VII activation that reg-
ulates the dependence of clot lag time on wall shear
rate. In this experiment, initial ratio of active factor VIIa
to inactive factor VII would be 1:1, so 1/2 of all com-
plexes of factor VII/VIIa with TF would be extrinsic
tenase (instead of 1% in normal plasma). This can be
interpreted as increase of extrinsic tenase activation
feedback speed, which allows to sufficiently neglect
influence of flow on the system.
On the other hand, addition of 5 nM TFPI (3-fold
increase of the normal plasma concentration) should
result in a dramatic increase of suppression by flow
(C
S
01 2  = 5.55) (Fig. 6), and the system sensitivity to
flow rate variation should also increase (R’ =4 . 5 ) .T F P I
would have very little effect in the absence of flow,
Figure 5 Kinetics of integral extrinsic tenase and inhibition of TF. (a) Integral extrinsic tenase kinetics under different flow conditions
(stagnant plasma (black), wall shear rate 7s
-1 (red) and 23s
-1(blue)) and in the case of no clot formation (dark yellow). Dotted arrows show the
lagtime. (b) Integral kinetics of TF inhibition under different flow conditions. Dotted line shows initial TF level.
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out flow. Increase of TFPI concentration would lead to
better inhibition of the feedback, thus system would be
more sensitive either to flow rate variation and suppres-
sion by flow. We propose that TFPI concentration is a
determining factor for the range of flow rate where the
coagulation system can form a clot.
As a possible control, addition of 6800 nM antithrom-
bin III (3-fold increase of the normal plasma concentra-
tion) should result in a very moderate increase of
suppression by flow (C
S
02 4  = 1.38), definitely much less
than in the case of TFPI addition (Fig. 6), and should
not change the sensitivity to flow rate variation suffi-
ciently (R’ = 1.22). So we propose that antithrombin III-
induced regulation of the early stages of coagulation in
flow is moderate.
Discussion
The principal conclusions of this study can be depicted
as a concept of clotting regulation by flow shown in Fig.
7. According to this concept, the critical step of blood
coagulation control in the presence of flow is drag-out
of factor Xa from the site of vascular damage by flow.
Without flow, quantities of extrinsic tenase formed by
TF and trace amounts of factor VIIa already present in
normal plasma are sufficient to generate enough factor
Xa in order to initiate clotting reaction. Additional acti-
vation of factor VII by factor Xa is not needed, and the
role of this reaction in the absence of flow is small.
Further, inhibition of extrinsic tenase by TFPI in the
absence of flow is not essential either, because of the
same reasons.
I nt h ep r e s e n c eo ff l o ww i t hl o ws h e a rr a t e s ,m o r e
extrinsic tenase is needed to clot plasma because factor
Xa is removed by flow. However, additional factor VIIa-
TF complex produced by factor Xa from factor VII-TF
complex can meet these requirements. Because of this
positive feedback, blood coagulation is almost not sensi-
tive to flow at low wall shear rates: with shear rate
increase, lagtime increases very slowly. The region of
this low sensitivity is determined by the balance of posi-
tive feedback of factor VII activation and TFPI-mediated
inhibition: the lagtime is sensitive to these reactions in
t h ep r e s e n c eo ff l o w( F i g .4 ) .T h i sr e s u l td i s a g r e e sw i t h
the theoretical prediction of [16], where TFPI was found
not to influence coagulation in flow at all. We suppose
that this disagreement was caused by different ways of
modeling TFPI inhibition [2].
Finally, at higher shear rates this mechanism is no
more able to support clotting: factor Xa is removed very
rapidly and is not able to activate factor VII-TF com-
plex. Lag time becomes very long and is rapidly increas-
ing as an exponential function of wall shear rate.
In other words, this concept can be summarized as
follows: positive feedback activation of factor VII-TF
complex by factor Xa, inhibition of factor VIIa-TF
Figure 6 The dependence of lag time on shear rate is determined by the factor VII activation, TFPI- and AT3-mediated inhibition. Lag
time is shown as a function of shear rate for normal plasma, and for plasma supplemented with factor VIIa, TFPI or AT3 as indicated in the
legend. Addition of factor VIIa results in dramatic lag time decrease and the dependence becomes linear (blue). Addition of TFPI shifts the
threshold to the region of lower shear rates (red). Addition of AT3 slightly increased lag time (dark yellow), compare to normal case. These
results indicate that factor VII activation and extrinsic tenase inhibition with TFPI are indeed the controlling mechanisms determining behavior of
coagulation in the presence of flow.
Shibeko et al. BMC Systems Biology 2010, 4:5
http://www.biomedcentral.com/1752-0509/4/5
Page 9 of 12complex by TFPI and factor Xa removal by flow from
the activation region together constitute a special con-
trolling mechanism, which makes blood coagulation
insensitive to flow at low shear rates, and almost com-
pletely switches clotting off at higher shear rates.
This concept agrees well with the theoretical predic-
tion of Beltrami and Jesty that a biochemical system
composed of two enzymes reciprocally activating each
other in the presence of flow, one enzyme being mem-
brane-bound and another being soluble, will depend on
the wall shear rate in a threshold manner[17]. A marked
difference between that prediction and the result
obtained here for coagulation system is that our, more
complex system does not actually have a clear threshold:
it is just a steep exponential dependence, which can,
however, serve the same regulatory purposes.
Generally speaking, flow can exert its effects by either
drag-in or drag-out of the components of coagulation.
Previous studies somewhat disagree in the relative contri-
bution of these phenomena. Experiments performed
using a reconstituted system and a continuous flow reac-
tor have shown that drag-in of rapidly consumable coa-
gulation factor predecessors (such as factor VIII) can be
very important and enhance coagulation [18]. Computer
simulations of fibrin polymerization [19] and enzyme cat-
alysis on the channel wall [17] in flow suggested that it is
the drag-out of these components which is the most
important mechanism of flow action. Our calculations
performed in a detailed model of coagulation system
agree with the latter conclusion: removal of coagulation
factors by flow is the predominant mechanism. More-
over, we were able to identify two most important factors
that are removed, factor Xa and thrombin. Convection of
other factors contributes negligibly.
Previous studies do not completely agree in their con-
clusions on flow effect in coagulation. Although there are
reports that blood flow can have some beneficial effect
on blood coagulation, at least in purified systems (for
example, the rate of factor X activation by extrinsic
tenase under high shear rate conditions is increased
[18,20]), it is more or less generally accepted that the
overall effect of flow on clotting is inhibitory as can be
seen from both flow chamber perfusion experiments and
in vivo studies [10,11,15,21,22]. The mechanisms of this
effect are not clear either. A recent mathematical model-
ing study has shown that flow can inhibit fibrin polymeri-
zation [19] and that this inhibition can give results
similar to those obtained experimentally [15]. The same
group showed that flow-mediated removal of factors IXa
and Xa inhibits the initiation of coagulation [16].
We studied the behavior of plasma coagulation
depending on the wall shear rate in the range of 0-28 s
-
1, and found out that at rates higher than 17-28 s
-1
plasma coagulation is almost inhibited by flow. It should
be considered that this range of wall shear rates signifi-
cantly depends on the activator size and the chosen
mechanism of gelation. If we take into consideration
that most researchers estimate physiological range of
Figure 7 Regulation of fibrin clotting by flow via the factor VII activation by factor Xa. The diagram illustrates the mechanisms controlling
initiation of coagulation in the presence of flow. Factor VIIa initially present in plasma binds to TF and activates factor X; it is also inhibits by TFPI.
Factor Xa can activate TF-bound factor VII in a positive feedback manner. In the absence of flow, both inhibition by TFPI and activation by factor
Xa are not significant, because high concentrations of TF present on fibroblast rapidly bind factor VIIa; they do not need additional factor VII
activation and are not particularly sensitive to factor VIIa-TF complex inhibition. When blood flow is present, factor Xa is rapidly removed, and
the rate of factor X production becomes insufficient to create fibrin clot (factor VIIa-TF complex being inhibited by TFPI). This is when factor Xa-
dependent feedback becomes important: factor Xa activates factor VII and increases its own production, counteracting the effects of flow. At
higher shear rates, this feedback is insufficient, and factor Xa production is strongly inhibited. Thus, inhibition of factor VIIa-TF complex by TFPI
and factor VII activation by factor Xa combine to create a threshold-like response of the system in flow: rapid clotting at low shear rates and
almost no thrombus formation at higher shear rates.
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-1 according to [23] then we
cannot escape the conclusion that the clotting system
function is actually designed to minimize fibrin thrombi
formation under physiological conditions. The problem
of fibrin polymerization in flow requires further explora-
tion, because it can essentially affect the range of shear
rates where clotting is possible; the qualitative phenom-
enon, however, should not change because it is deter-
mined by flow effect on factors IIa and Xa.
Summarizing, our results suggest that roles of the
initial reactions of the extrinsic pathway might be some-
what reconsidered. In particular, this is relevant for factor
VII-TF complex activation by factor Xa and factor VIIa-
TF complex inhibition by TFPI. In the absence of flow,
these reactions do not have clear roles. Although they
can influence clotting activated with diluted TF in vitro
[13,24], their contribution in the presence of TF highly
concentrated on fibroblasts is negligible in the conditions
of this study: formation of extrinsic tenase is sufficient
without any need of additional factor VIIa, and inhibition
by TFPI cannot significantly delay clotting [13]. On the
other hand, in the presence of flow, which removes factor
Xa (both the product and the activator of extrinsic
tenase) these reactions become critically important and
completely shape the response of the system.
Conclusions
Removal of factor Xa by flow is the predominant
mechanism of flow influence on the initial stage of
blood coagulation. Together with TFPI-induced inhibi-
tion of extrinsic tenase complex, these mechanisms pro-
vide strongly non-linear response making coagulation
insensitive to flow at low shear rates and almost pre-
venting coagulation at higher rates. Although elucidation
of these purposes is beyond the scope of this study, it
might be speculated that this mechanism can protect
the vascular system from formation of fibrin thrombi at
high shear rates. However, when blood flow is reduced
(e.g., as a result of platelet plug formation), the clotting
in the area without flow can proceed rapidly.
Methods
Mathematical model
A detailed mathematical model of blood coagulation
cascade previously developed and verified by our group
[4] for clotting of plasma without flow was used with
modifications that included addition of a second dimen-
sion, convection terms, Navier-Stokes equations, and the
process of fibrin polymerization as described below. The
m o d e lc o n s i s t e do f2 8p a r t i a ld i f f e r e n t i a le q u a t i o n s
describing biochemical reactions, diffusion and convec-
tion of the reactants. All initial concentrations and
kinetic constants used in the model were obtained from
experimental reports, and no adjustment was performed.
The model simulated coagulation in a two-dimen-
sional rectangle region (1,000 × 6,000 μm) with laminar
flow. Activation patch (1,000 μm) covered with tissue
factor (TF) was located on one of the walls of the simu-
lated channel. When coagulation was activated, it led to
fibrin network formation. We assumed the rate of fibrin
polymerization to be sufficiently high so that each fibrin
molecule was rapidly incorporated into the network;
thus, we neglected the effect of flow on fibrin fibers for-
mation. The permeability of this network was assumed
to depend on fibrin concentration. While fibrin concen-
tration was below the point of gelation, the permeability
was 1, and it reduced to 0 when the fibrin concentration
exceeded the critical concentration. Although imperme-
able to flow, fibrin gel in the model did not hinder diffu-
sion [25] and was assumed to have no effect on the
reactions of coagulation except for thrombin adsorption
onto fibrin. The detailed description of the model is
available in Additional file 3 and program realization of
mathematical simulation based on this model is pre-
sented in Additional file 4.
Modular analysis
In order to identify reactions responsible for the regula-
tion of clotting by flow, we introduced a parameter
characterizing the time of initiation phase. Lagtime was
defined as the time when clot reached the middle of the
activator. We measured the dependence of lagtime on
flow rate and obtained the normal behavior of the sys-
tem, so that we could trace its variations when perturb-
ing the system. In order to quantify lagtime dependence
on flow rate we used the following coefficient:
C
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(1)
This is comparative flow influence coefficient in range
of flow rates i-j (from i s
-1 up to j s
-1). Each set of simu-
lation results was approximated with the exponential
function y = y0 + A·e
R·x. Parameter
  R
R
Rnorma
(2)
was used as relative flow rate variation sensitivity
coefficient.
The first coefficient indicates the integral flow induced
lagtime growth within the certain range of flow rates,
and the second coefficient indicates the increase of the
rate of lagtime growing in the dependence lagtime ver-
sus flow rate. Based on values of these parameters, we
could decide whether a certain part of coagulation
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flow conditions.
Additional file 1: Thrombus formation without flow. Movie
representing simulation of thrombus in stagnant plasma (movie time/real
time is 1/90).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-0509-4-5-
S1.MOV]
Additional file 2: Thrombus formation under flow conditions. Movie
representing simulation of thrombus in flowing plasma (movie time/real
time is 1/90). Wall shear rate is 17 s
-1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-0509-4-5-
S2.MOV]
Additional file 3: Mathematical model of blood coagulation in the
presence of flow. Description of the mathematical model and of the
numerical methods.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-0509-4-5-
S3.DOC]
Additional file 4: Program code files. Source files of program
realization of blood coagulation modeling under flow conditions.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-0509-4-5-
S4.ZIP]
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